Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells
Immunity · 2026
DOI: 10.1016/j.immuni.2026.09.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2026. Verfasst von Benoît Manfroi und 35 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, 75015 Paris, France. Hauptthemen laut MEDLINE: Interleukin-10, Encephalomyelitis, Autoimmune, Experimental, B-Lymphocytes, Regulatory, Myeloid Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: AXA Research Fund, Université Sorbonne Paris Cité, Socialist Republic of Vietnam Ministry of Science and Technology.
Abstract (Originalsprache)
The lack of approaches to produce interleukin (IL)-10-producing B cells at high frequency has hampered mechanistic investigation into the generation, fate, and activity of these regulatory cells. We screened pharmacological compounds for their ability to induce IL-10 expression in B cells. One compound, N6, promoted stable IL-10 expression in >95% of B cells. Transfer of IL-10+ B cells induced remission of experimental autoimmune encephalomyelitis. N6-induced B cells accumulated in the central nervous system (CNS) and differentiated into IL-10+ plasma cells, promoting transcriptional and phenotypic changes in myeloid cells within the CNS. The therapeutic effect of IL-10+ B cell transfer was abrogated in mice lacking IL-10 receptor expression in long-lived myeloid cells, pointing to microglia as targets of B cell-derived IL-10. Importantly, an N6 analog corrected defective IL-10 expression in B cells from multiple sclerosis patients. Our findings establish a pharmacological strategy to generate IL-10+ B cells with therapeutic potential and identify microglia as critical targets for intercepting neuroinflammatory disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, 75015 Paris, France.
- Deutsches Rheuma-Forschungszentrum, A Leibniz Institute, Berlin, Germany; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Be…
- Department of Genetics/Epigenetics, Saarland University, Saarbrücken, Germany.
- Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, 75015 Paris, France; CNRS UMR 9187, INSERM U1196, Chemistry and Modeling for the Biological of Cancer, Institut Curie, PSL Research Uni…
- CNRS UMR 9187, INSERM U1196, Chemistry and Modeling for the Biological of Cancer, Institut Curie, PSL Research University, 91405, Orsay, France; CNRS UMR 9187, INSERM U1196, Chemistry and Modeling for the Biological of…
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Physics of Cells and Cancer, 75005 Paris, France.
Förderung
- AXA Research Fund
- Université Sorbonne Paris Cité
- Socialist Republic of Vietnam Ministry of Science and Technology
- Medical Research Foundation at the University Hospital Erlangen
- French Multiple Sclerosis Foundation
- European Research Council
- Institut Merieux
Zitieren
APA
Manfroi, B., Dang, V. D., Cuc, B. T., Jungmann, A., Borzakian, S., Tong, Y., Beauvineau, C., Dupuis, L., Guffart, E., Borst, K., Nguyen, N. T., Wu, Z., Alvarez-Simon, D., Chyzak, G., Schäfer, S., Gerlach, R. G., Frischbutter, S., Hamann, A., Wehbe, L. S., …, & Fillatreau, S. (2026). Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells. Immunity. https://doi.org/10.1016/j.immuni.2026.09.006
Vancouver
Manfroi B, Dang VD, Cuc BT, Jungmann A, Borzakian S, Tong Y, et al. Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells. Immunity. 2026. doi:10.1016/j.immuni.2026.09.006
BibTeX
@article{Manfroi2026,
author = {Manfroi, Benoît and Dang, Van Duc and Cuc, Bui Thi and Jungmann, Annemarie and Borzakian, Sibyline and Tong, Yanli and Beauvineau, Claire and Dupuis, Louise and Guffart, Elena and Borst, Katharina and Nguyen, Ngan Thu and Wu, Zhiguo and Alvarez-Simon, Daniel and Chyzak, Guillaume and Schäfer, Simon and Gerlach, Roman G and Frischbutter, Stefan and Hamann, Alf and Wehbe, Layale Salem and El Behi, Mohamed and Luka, Marine and Ménager, Mickaël and Jouneau, Luc and Boudinot, Pierre and Jung, Steffen and Winkler, Thomas H and Liblau, Roland and Marignier, Romain and Isambert, Hervé and Prinz, Marco and Amann, Lukas Simon and von Kries, Jens Peter and Specker, Edgar and Walter, Jörn and Mahuteau-Betzer, Florence and Fillatreau, Simon},
title = {Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells},
journal = {Immunity},
year = {2026},
doi = {10.1016/j.immuni.2026.09.006}
}
EUVIMED